Malaysia Pharmaceutical Consulting

Malaysia’s pharmaceutical market is worth about $1 billion. This small-to-medium-sized pharmaceutical market has potential to grow with increasing government healthcare spending and greater health awareness among Malaysians. PBM has worked on many Malaysia pharmaceutical consulting projects. We have assisted clients in registering drugs, finding local distributors and establishing drug manufacturing facilities in Malaysia.

There are less than 100 local drug manufacturers in Malaysia. Most of these manufacturers produce generic drugs. Since the financial crisis of 2008-2010, generic drugs have gained popularity in local hospitals and clinics due to their price affordability.

There is also an increasing demand for specialist treatment among middle and upper-class Malaysians, due to lifestyle-related diseases such as heart disease and cancer. The treatment of these diseases has led to higher imports of more advanced pharmaceutical products, primarily from the US, Japan and Germany. International drug companies who wish to export their products into Malaysia can approach a PBM Malaysian pharmaceutical consultant for assistance.

To successfully enter the Malaysian drug market, international drug companies need to understand its regulatory dynamics. The Malaysian pharmaceutical market is regulated by the country’s Drugs Control Authority (DCA). The main responsibility of the DCA is to ensure the safety, quality and efficacy of pharmaceuticals in Malaysia. Other duties of the DCA include reviewing registration applications for drugs and cosmetics, licensing importers, manufacturers and wholesalers and conducting post-marketing safety surveillance.

PBM’s Malaysia pharmaceutical consultants possess the industry knowledge and experience to guide international companies through the Malaysian drug market. Our pharmaceutical consulting services utilize the best solutions to help you succeed.

Please contact us for inquiries about PBM’s consultant services, or browse PBM’s publications for further information on Malaysia’s healthcare market.